Evolution of Adipokines and Body Composition in Rheumatoid Arthritis Patients Receiving Tocilizumab Therapy

Sponsor
Centre Hospitalier Universitaire de Besancon
Study ID
NCT02843789
Phase
PHASE4
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 80 Years
Healthy Volunteers
Not accepted

Interventions

Study Details

The aim of this study is to analyze the variation of adiponectinemia and its molecular forms in RA patients receiving tocilizumab therapy.

Key Dates

Start date
Mar 31, 2013
Status verified
Feb 2018
Primary completion
Nov 30, 2017
Completion
Nov 30, 2017

Study Design

Enrollment
109 participants (actual)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Adiponectin evaluation
    Patients evaluated for serum adiponectin level and for body composition before each infusion of Tocilizumab

Primary Outcome Measure

Serum total adiponectin (ng/ml) [ Time Frame: 12 months ]

Related Studies